VisExcell Overview

  • Founded
  • 2015
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

VisExcell General Information


Developer of a breast cancer risk judgement platform designed to reduce the risk of breast cancer. The company's breast cancer risk judgement platform uses machine learning and computer vision to deliver risk models and automated physician annotation through the use of mammograms, enabling women to assess the risk of breast cancer.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 2211 Bryn Mawr Avenue
  • Ardmore, PA 19003
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

VisExcell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Nov-2019 00000 Completed Out of Business
2. Early Stage VC 04-Mar-2016 00000 00000 Completed Startup
1. Accelerator/Incubator 26-Oct-2015 $50K $50K 00000 Completed Startup
To view VisExcell’s complete valuation and funding history, request access »